1. Home
  2. DAC vs NBTX Comparison

DAC vs NBTX Comparison

Compare DAC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$129.51

Market Cap

2.2B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$41.24

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAC
NBTX
Founded
1972
2003
Country
Greece
France
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
DAC
NBTX
Price
$129.51
$41.24
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$112.50
$36.00
AVG Volume (30 Days)
72.6K
82.8K
Earning Date
05-14-2026
03-31-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$58.17
Revenue Next Year
N/A
N/A
P/E Ratio
$4.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$83.56
$4.93
52 Week High
$135.21
$57.14

Technical Indicators

Market Signals
Indicator
DAC
NBTX
Relative Strength Index (RSI) 59.74 58.42
Support Level $121.29 $38.89
Resistance Level $134.25 $42.40
Average True Range (ATR) 2.75 2.28
MACD 0.62 0.47
Stochastic Oscillator 84.46 80.61

Price Performance

Historical Comparison
DAC
NBTX

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: